These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16870440)

  • 1. Carbonic anhydrase activators: the first X-ray crystallographic study of an adduct of isoform I.
    Temperini C; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5152-6. PubMed ID: 16870440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators.
    Temperini C; Scozzafava A; Puccetti L; Supuran CT
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5136-41. PubMed ID: 16214338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme.
    Temperini C; Scozzafava A; Vullo D; Supuran CT
    Chemistry; 2006 Sep; 12(27):7057-66. PubMed ID: 16807956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a topically acting antiglaucoma sulfonamide.
    Abbate F; Casini A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 May; 14(9):2357-61. PubMed ID: 15081040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallographic studies of inhibitor binding sites in human carbonic anhydrase II: a pentacoordinated binding of the SCN- ion to the zinc at high pH.
    Eriksson AE; Kylsten PM; Jones TA; Liljas A
    Proteins; 1988; 4(4):283-93. PubMed ID: 3151020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and kinetic characterization of active-site histidine as a proton shuttle in catalysis by human carbonic anhydrase II.
    Fisher Z; Hernandez Prada JA; Tu C; Duda D; Yoshioka C; An H; Govindasamy L; Silverman DN; McKenna R
    Biochemistry; 2005 Feb; 44(4):1097-105. PubMed ID: 15667203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme.
    Chakravarty S; Kannan KK
    J Mol Biol; 1994 Oct; 243(2):298-309. PubMed ID: 7932756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine.
    Briganti F; Mangani S; Orioli P; Scozzafava A; Vernaglione G; Supuran CT
    Biochemistry; 1997 Aug; 36(34):10384-92. PubMed ID: 9265618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speeding up proton transfer in a fast enzyme: kinetic and crystallographic studies on the effect of hydrophobic amino acid substitutions in the active site of human carbonic anhydrase II.
    Fisher SZ; Tu C; Bhatt D; Govindasamy L; Agbandje-McKenna M; McKenna R; Silverman DN
    Biochemistry; 2007 Mar; 46(12):3803-13. PubMed ID: 17330962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase activators: kinetic and X-ray crystallographic study for the interaction of D- and L-tryptophan with the mammalian isoforms I-XIV.
    Temperini C; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2008 Sep; 16(18):8373-8. PubMed ID: 18774300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.
    De Simone G; Di Fiore A; Menchise V; Pedone C; Antel J; Casini A; Scozzafava A; Wurl M; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2315-20. PubMed ID: 15837316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: stereospecific recognition within the active site of an enzyme and its consequences for the drug design.
    Temperini C; Scozzafava A; Vullo D; Supuran CT
    J Med Chem; 2006 May; 49(10):3019-27. PubMed ID: 16686544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosph(on)ate as a zinc-binding group in metalloenzyme inhibitors: X-ray crystal structure of the antiviral drug foscarnet complexed to human carbonic anhydrase I.
    Temperini C; Innocenti A; Guerri A; Scozzafava A; Rusconi S; Supuran CT
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2210-5. PubMed ID: 17314045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct--an inhibitor mimicking the sulfonamide and urea binding to the enzyme.
    Temperini C; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2010 Jan; 20(2):474-8. PubMed ID: 20005709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton transfer in a Thr200His mutant of human carbonic anhydrase II.
    Bhatt D; Tu C; Fisher SZ; Hernandez Prada JA; McKenna R; Silverman DN
    Proteins; 2005 Nov; 61(2):239-45. PubMed ID: 16106378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors: the X-ray crystal structure of the adduct of N-hydroxysulfamide with isozyme II explains why this new zinc binding function is effective in the design of potent inhibitors.
    Temperini C; Winum JY; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 May; 17(10):2795-801. PubMed ID: 17346964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and kinetic analysis of proton shuttle residues in the active site of human carbonic anhydrase III.
    Elder I; Fisher Z; Laipis PJ; Tu C; McKenna R; Silverman DN
    Proteins; 2007 Jul; 68(1):337-43. PubMed ID: 17427958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
    Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
    Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II.
    Menchise V; De Simone G; Di Fiore A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6204-8. PubMed ID: 17000110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomic crystal and molecular dynamics simulation structures of human carbonic anhydrase II: insights into the proton transfer mechanism.
    Fisher SZ; Maupin CM; Budayova-Spano M; Govindasamy L; Tu C; Agbandje-McKenna M; Silverman DN; Voth GA; McKenna R
    Biochemistry; 2007 Mar; 46(11):2930-7. PubMed ID: 17319692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.